Rituximab induced cytokine release syndrome in an MS patient: A case report

Cytokine release syndrome with rituximab has been reported in certain diseases, however, it is rarely reported in MS patients treated with rituximab. The treating physician should suspect the syndrome when typical signs and symptoms appear.

Detalles Bibliográficos
Autores principales: Etemadifar, Masoud, Salari, Mehri, Saeri, Mahdieh, Sigari, Amirhossein Akhavan, Ebrahimi Pelarti, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271264/
https://www.ncbi.nlm.nih.gov/pubmed/34267900
http://dx.doi.org/10.1002/ccr3.4407
_version_ 1783720962611478528
author Etemadifar, Masoud
Salari, Mehri
Saeri, Mahdieh
Sigari, Amirhossein Akhavan
Ebrahimi Pelarti, Sara
author_facet Etemadifar, Masoud
Salari, Mehri
Saeri, Mahdieh
Sigari, Amirhossein Akhavan
Ebrahimi Pelarti, Sara
author_sort Etemadifar, Masoud
collection PubMed
description Cytokine release syndrome with rituximab has been reported in certain diseases, however, it is rarely reported in MS patients treated with rituximab. The treating physician should suspect the syndrome when typical signs and symptoms appear.
format Online
Article
Text
id pubmed-8271264
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82712642021-07-14 Rituximab induced cytokine release syndrome in an MS patient: A case report Etemadifar, Masoud Salari, Mehri Saeri, Mahdieh Sigari, Amirhossein Akhavan Ebrahimi Pelarti, Sara Clin Case Rep Case Reports Cytokine release syndrome with rituximab has been reported in certain diseases, however, it is rarely reported in MS patients treated with rituximab. The treating physician should suspect the syndrome when typical signs and symptoms appear. John Wiley and Sons Inc. 2021-07-09 /pmc/articles/PMC8271264/ /pubmed/34267900 http://dx.doi.org/10.1002/ccr3.4407 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Etemadifar, Masoud
Salari, Mehri
Saeri, Mahdieh
Sigari, Amirhossein Akhavan
Ebrahimi Pelarti, Sara
Rituximab induced cytokine release syndrome in an MS patient: A case report
title Rituximab induced cytokine release syndrome in an MS patient: A case report
title_full Rituximab induced cytokine release syndrome in an MS patient: A case report
title_fullStr Rituximab induced cytokine release syndrome in an MS patient: A case report
title_full_unstemmed Rituximab induced cytokine release syndrome in an MS patient: A case report
title_short Rituximab induced cytokine release syndrome in an MS patient: A case report
title_sort rituximab induced cytokine release syndrome in an ms patient: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271264/
https://www.ncbi.nlm.nih.gov/pubmed/34267900
http://dx.doi.org/10.1002/ccr3.4407
work_keys_str_mv AT etemadifarmasoud rituximabinducedcytokinereleasesyndromeinanmspatientacasereport
AT salarimehri rituximabinducedcytokinereleasesyndromeinanmspatientacasereport
AT saerimahdieh rituximabinducedcytokinereleasesyndromeinanmspatientacasereport
AT sigariamirhosseinakhavan rituximabinducedcytokinereleasesyndromeinanmspatientacasereport
AT ebrahimipelartisara rituximabinducedcytokinereleasesyndromeinanmspatientacasereport

Ejemplares similares